Medicare Enrolled
Dr. Jason Appelbaum, M.D.
Cardiovascular Disease · Atlantis, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Appelbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Appelbaum? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Appelbaum
Dr. Jason Appelbaum is a cardiovascular disease in Atlantis, FL, with 13 years in practice. Based on federal Medicare data, Dr. Appelbaum performed 3,630 Medicare services across 2,368 unique beneficiaries.
Between the years covered by Open Payments, Dr. Appelbaum received a total of $66,338 from 24 pharmaceutical and/or device companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Appelbaum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 33% volume in FL$ $66,338 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,630
Medicare services
Top 33% in FL for cardiovascular disease
2,368
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~279 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 490 | $21 | $165 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 467 | $29 | $192 |
| Office visit, established patient (30-39 min) | 412 | $96 | $662 |
| Electrocardiogram (EKG), 12-lead | 401 | $11 | $76 |
| Ultrasound of heart with probe in esophagus, with report | 135 | $85 | $543 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 135 | $2 | $15 |
| Programming of heart rhythm stimulation after drug infusion | 130 | $69 | $456 |
| Initial hospital admission, high complexity | 117 | $142 | $927 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 111 | $824 | $5,446 |
| New patient office visit, complex (60-74 min) | 106 | $178 | $1,150 |
| Evaluation of cardiac rhythm monitor system | 93 | $36 | $256 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 88 | $267 | $1,712 |
| New patient office visit (45-59 min) | 78 | $128 | $873 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 77 | $233 | $1,486 |
| External shock to heart to regulate heart beat | 72 | $88 | $564 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 69 | $6 | $37 |
| Programming of dual lead pacemaker system | 67 | $60 | $406 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 66 | $267 | $1,714 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 62 | $21 | $134 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 62 | $659 | $4,330 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $14 | $90 |
| Evaluation of implantable heart and blood vessel monitoring system | 46 | $36 | $280 |
| Insertion of heart rhythm monitor under skin | 44 | $76 | $487 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 36 | $52 | $383 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 33 | $728 | $4,669 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 30 | $145 | $924 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $402 | $2,873 |
| Insertion of implantable defibrillator system | 21 | $755 | $5,091 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 20 | $38 | $279 |
| Office visit, established patient (20-29 min) | 19 | $51 | $472 |
| Hospital follow-up visit, high complexity | 17 | $97 | $605 |
| Programming of dual lead implantable defibrillator system | 12 | $77 | $488 |
| Destruction of heart conduction tissue to create heart block | 12 | $485 | $3,258 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $58 | $404 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.6% high complexity
4.0% medium
73.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$66,338
Total received (2018-2024)
Avg $9,477/year across 7 years
Top 6% in FL for cardiovascular disease
24
Companies
310
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Scientific / Research
Research funding and grants
$26,160 (39.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,029 (34.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,225 (24.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$924 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$24,020
2023$5,912
2022$1,406
2021$1,064
2020$2,435
2019$16,608
2018$14,892
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$21,124
Medical Device Business Services, Inc.
$14,006
Biosense Webster, Inc.
$12,241
Boston Scientific Corporation
$8,351
BOSTON SCIENTIFIC CORPORATION
$3,567
Abbott Laboratories
$2,137
Medtronic, Inc.
$1,499
ATRICURE, INC.
$978
CARDIVA MEDICAL, INC.
$497
Philips North America LLC
$369
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$290
AtriCure, Inc.
$265
GE HEALTHCARE
$218
Impulse Dynamics (USA) Inc.
$186
SANOFI-AVENTIS U.S. LLC
$155
Siemens Medical Solutions USA, Inc.
$142
PFIZER INC.
$94
Janssen Pharmaceuticals, Inc
$86
Kestra Medical Technology Services, Inc.
$39
E.R. Squibb & Sons, L.L.C.
$26
CHIESI USA, INC.
$20
Novartis Pharmaceuticals Corporation
$20
AstraZeneca Pharmaceuticals LP
$16
Terumo Medical Corporation
$14
Top 3 companies account for 71.4% of total payments
Associated products mentioned in payments ›
(BK5) Azurion 5 M20 · (CM9) Amb Mon & Diag Und · (P84) IGT Devices Systems · AMPLATZER AMULET · ARCTIC FRONT ADVANCE · ATRICURE ATRICLIP LAA EXCLUSION · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Allia · Assure WCD · Assurity Pacemaker · Azure · BRILINTA · BodyGuardian · CARDIOBLATE CRYOFLEX · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CLARIA MRI QUAD CRT-D SURESCAN · COBALT DR MRI SURESCAN · CONFIRM RX · Cardiva VASCADE MVP VVCS 6-12F · Carto 3 · Carto 3 System · Cios Alpha · Confirm Rx · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · EMBLEM S-ICD ELECTRODE DELIVERY SYSTEM · ENSITE · ENSITE PRECISION · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Ellipse ICD · Ensite Cardiac Mapping System · FlexAbility Ablation Catheter · Fortify Assura · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL THERAPIES · KENGREAL · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MODELS · MULTAQ · MYCARELINK · Micra · NUVISION ICE CATHETER · OCTARAY MAPPING CATHETER · Optimizer · Paceart · QDOT MICRO Catheter · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · REVEAL LINQ · RHYTHMIA · SELECTSECURE · SYNERGY ABLATION SYSTEM · Soundstar · THERMOCOOL SMARTTOUCH · TYRX · Thermocool SF · VADO · VISITAG SURPOINT External Processing Unit · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (39%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 6% for cardiovascular disease in FL.
Equivalent to $1,827 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
165
Per 100K population
10.9
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Appelbaum is a remote & electrophysiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 6%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Appelbaum experienced with evaluation of cardiac rhythm monitor system, remote up to 30 days?
Based on Medicare claims data, Dr. Appelbaum performed 490 evaluation of cardiac rhythm monitor system, remote up to 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Appelbaum receive payments from pharmaceutical companies?
Yes. Dr. Appelbaum received a total of $66,338 from 24 companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Appelbaum's costs compare to other cardiovascular diseases in Atlantis?
Dr. Appelbaum's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Appelbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Atlantis
Browse cardiovascular diseases in Atlantis ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology